Speech Therapy—A Non-Pharmacological Method to Manage Difficult-to-treat Chronic Cough

Krakowiak, Karolina; Dąbrowska, Marta; Buła, Filip; Łobacz, Anna; Rojek, Dorota; Grabczak, Elżbieta M.; Krzeski, Antoni; Krenke, Rafał

doi:10.5603/arm.2017.0018

Cited by 7 publications

(5 citation statements)

References 18 publications

(41 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore it was so important for us to implement that technique and assess its efficacy in Polish population, since such a therapeutic approach had not been commonly used in Poland before. To our knowledge there has been only one case report published so far, which referred to trial of speech therapy in management of difficult-to-treat chronic cough in Poland [25].…”

Section: Discussionmentioning

confidence: 99%

Speech Therapy in the Management of Difficult-to-Treat Chronic Cough—Preliminary Results

Dąbrowska

Grabczak

Rojek

et al. 2018

Advances in Respiratory Medicine

Self Cite

View full text Add to dashboard Cite

Introduction: The efficacy of management of chronic cough in adults is limited. Speech therapy is one of the few therapeutic methods which seems to be useful in patients with persistent chronic cough. However, the method has not been available in Poland so far. The aim of the study was to implement speech therapy and assess its efficacy in the management of patients with difficult-to-treat chronic cough. Material and methods: Patients, who were diagnosed and managed due to difficult-to-treat chronic cough, were enrolled into the study. Speech therapy was developed on the basis of the technique described by Vertigan. The entire therapy consisted of eight weekly sessions, each lasting 45 minutes. Before and after speech therapy, cough severity and its impact on the quality of life was assessed by the Visual Analogue Scale (VAS) and Leicester Cough Questionnaire (LCQ). Additionally, cough challenge test with capsaicin was performed. Results: Eighteen women were enrolled into the study, 15 of them (83%) attended all treatment sessions (median age 66 years, median duration of cough 60 months). There was a significant decrease in cough severity measured by VAS (46 vs 28 mm, p = 0.016) after completion of speech therapy. A significant improvement in patients' quality of life measured by LCQ (10.7 vs 14.6 points, p = 0.004) and an increase in the threshold of cough reflex measured by capsaicin challenge were also demonstrated. Conclusions: Speech therapy resulted in a decrease in cough severity and improvement of quality of life of females with refractory chronic cough. Our results support the use of speech therapy as add-on treatment in females with difficult-to-treat cough.

show abstract

Section: Discussionmentioning

confidence: 99%

Speech Therapy in the Management of Difficult-to-Treat Chronic Cough—Preliminary Results

Dąbrowska

Grabczak

Rojek

et al. 2018

Advances in Respiratory Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

“…Reducing laryngeal stimulation can slow the speed of reaching the cough threshold, and maintaining laryngeal hydration and laryngeal massage can reduce the laryngeal hypersensitivity response, thus reducing the laryngeal muscle spasm or vocal cord abnormal movement caused by laryngeal stimulation and reducing the risk of subsequent injury. Breathing exercises are conducive to reducing adductor activity during expiration, thus reducing coughing [ 33 ].…”

Section: Possible Mechanisms Underlying Non-pharmacologic Therapymentioning

confidence: 99%

Management of non-pharmacologic therapy for chronic refractory cough: Mechanism, composition, applicable population, and assessment

Peng,

Zhang,

Yuan

et al. 2023

Heliyon

View full text Add to dashboard Cite

“…91 In an open study design, Ryan et al 92 identified that SPT improved cough-related quality of life and cough reflex sensitivity, which has also been evidenced by several case series that consisted of small patient populations and no control groups. 93,94 Vertigan et al 95 conducted a randomized, placebo-controlled study that enrolled 87 patients (mean age = 59.4 years, 74% female) with CRC who were randomly assigned 4 individual 30-minute intervention sessions recorded over a 60-day period (intervention) or healthy lifestyle education (placebo). The treatment group had a significant reduction in negative symptoms associated with cough (P < 0.001), breathing (P < 0.001), voice (P < 0.001), upper airway (P < 0.001), and symptom limitation on daily activities (P < 0.001) following the intervention.…”

Section: Speech Pathology Treatmentmentioning

confidence: 99%

Treatment of Chronic Refractory Cough in Adults: Focus on Neuromodulators and Other Therapeutic Modalities

O’Hare

Rahman

Williams

2020

Journal of Pharmacy Technology

View full text Add to dashboard Cite

Objective: To evaluate the literature and educate health care professionals about the different management options for chronic refractory cough (CRC). Data Sources: Searches were performed through MEDLINE (1966 to July 2020) using OVID and EBSCOhost and EMBASE (1947 to July 2020) using OVID. Search terms included chronic cough, neurogenic cough, neuromodulators, chronic cough management, and chronic cough treatment. References of all relevant articles were further used to obtain additional articles. Study Selection and Data Extraction: This review includes articles in the English language and human trial literature. Twenty-three trials explored the use of oral neuromodulators in the management of CRC. Data Synthesis: CRC is a poorly understood disease that may have a complex neuropathic etiology. Oral neuromodulators, such as amitriptyline, baclofen, gabapentin, and pregabalin, continue to be the most commonly used agents for the management of CRC. Alternative pharmacological therapies such as botulinum toxin, anesthetic agents (benzonatate, lidocaine), and narcotic agents have efficacy data, and further research into effective doses and routes of administration is warranted. Alternative nonpharmacologic therapies more commonly used included speech pathology treatment. Conclusion: Several medication and alternative treatment interventions may be effective in managing CRC. Current studies used wide dosing and titration strategies, making it challenging to standardize therapy. No consistent method of assessing cough reflex was used between studies, as well as a lack of consistent randomization and small sample sizes. Additional research is needed to standardize treatment durations, optimum doses, and place in therapy of the available interventions in the management of CRC.

show abstract

Speech Therapy—A Non-Pharmacological Method to Manage Difficult-to-treat Chronic Cough

Cited by 7 publications

References 18 publications

Speech Therapy in the Management of Difficult-to-Treat Chronic Cough—Preliminary Results

Speech Therapy in the Management of Difficult-to-Treat Chronic Cough—Preliminary Results

Management of non-pharmacologic therapy for chronic refractory cough: Mechanism, composition, applicable population, and assessment

Treatment of Chronic Refractory Cough in Adults: Focus on Neuromodulators and Other Therapeutic Modalities

Contact Info

Product

Resources

About